Pharmerica Corp (PMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 442,000 | 458,500 | 498,900 | 495,600 | 518,700 |
| Cost of Goods | 365,900 | 382,600 | 426,300 | 419,500 | 443,000 |
| Gross Profit | 76,100 | 75,900 | 72,600 | 76,100 | 75,700 |
| Operating Expenses | 64,700 | 61,300 | 60,900 | 60,500 | 65,000 |
| Operating Income | 12,300 | 15,200 | 12,000 | 16,100 | 10,700 |
| Interest Expense | 2,400 | 2,500 | 2,700 | 2,500 | 2,600 |
| Pre-tax Income | 9,900 | 12,700 | 9,300 | 13,600 | 8,100 |
| Income Tax | 3,900 | 5,100 | 3,700 | 5,700 | 3,300 |
| Net Income Continuous | 6,000 | 7,600 | 5,600 | 7,900 | 4,800 |
| Net Income | $6,000 | $7,600 | $5,600 | $7,900 | $4,800 |
| EPS Basic Total Ops | 0.20 | 0.26 | 0.19 | 0.28 | 0.16 |
| EPS Basic Continuous Ops | 0.20 | 0.26 | 0.19 | 0.27 | 0.16 |
| EPS Diluted Total Ops | 0.20 | 0.26 | 0.19 | 0.27 | 0.16 |
| EPS Diluted Continuous Ops | 0.20 | 0.26 | 0.19 | 0.27 | 0.16 |
| EBITDA(a) | $20,400 | $22,900 | $19,800 | $24,000 | $18,700 |